Ignacio J. Amat
@ignamatsant
Chief, interventional Cardiologist in HCU Valladolid & H Campogrande
Ever wanted to learn the most complex interventional techniques without risk for your patients? Then TACIT MEETING is for you!! 👉simulators based 👉top experts at your side 👉live cases 👉Join now❗️ tacitmeeting.com @PCRonline @TCTMD @shci_sec @solaci_online
Estrategia de reducción de stents frente a revascularización coronaria percutánea convencional en el IAMCEST: diseño del ensayo COPERNICAN #REC #Aheadofprint @sjorge4 @drassantos @EvaRumiz @AntonioGomezM21 @fer_iver @cardioyoguini @hect2701 @ignamatsant revespcardiol.org/es-estrategia-…
Just published in Catheterization our comparison of Myval & ACURATE neo2 at 4-year FU @PCRonline @RevEspCardiol @secardiologia onlinelibrary.wiley.com/doi/10.1002/cc…
What's special about this new trilingual Course for the LATAM Heart Team? ⏯️ Watch Vinicius Esteves and Flavio Ribichini to find out what sets #PCRRioValves apart (11-12 September, Rio de Janeiro)️ Register now and secure your place! pcronline.com/Courses/PCR-Ri… @vinesteves…
Commissural alignment with the Allegra transcatheter aortic bioprosthesis #REC #Aheadofprint @sjorge4 @jasorolla @jp_vilchez @ignamatsant @JL_10_HILL ow.ly/F3tq50WoTUb
En este nuevo episodio del podcast, el Dr. @ignamatsant nos cuenta los resultados del artículo publicado en @EuroInterventio acerca de la Durabilidad a mediano plazo de la válvula Myval (Meril). Recuerden suscribirse al canal. youtu.be/WGTYwYABi1c @pemarlor08 @MPAOSS…
PCRLV 25 will once again be yours. Deadline for submission Sept 2nd. The largest, most educational and inclusive valve course worldwide : our place to share solutions🔥🔥! @PCRonline
Guess what’s still missing from #PCRLV? 👉Your submissions! Send in your Scientific Abstracts, Clinical Cases, Innovations and Late-Breaking Trials by 2 September 📩 🗓️PCR London Valves | 16-18 November pcronline.com/Courses/PCR-Lo…
Four-year follow-up data from this multicentre study of the balloon-expandable Myval TAVI system report valve-related outcomes including haemodynamic deterioration, bioprosthetic valve failure, and patient–prosthesis mismatch, as defined by VARC-3. eurointervention.pcronline.com/article/four-y… #TAVI…
Now online the 4-year durability data for Myval THV in @EuroInterventio 👉 eurointervention.pcronline.com/article/four-y… 👉 Great job from our fellow @Aku92cardio 👉Thanks to all co-authors and to Drs @PPibarot and @ericvanbelle for their Editorial eurointervention.pcronline.com/article/the-ne…
Watch the latest OPCI Journal Club "Primary Results of the TELLTALE IDE Trial" with @CathElectroSurg and panelists @djc795 @ziadalinyc and Dr. William Chung. opci.live/opci-lives/pri…
TAVR SUMMIT en Bogotá 10-12 Julio’25‼️ 👉Hot topics 👉International experts 👉Hand-on BASILICA @luisareizat @nicolo_piazza @HemalGada @sccccardio @lamelaspablo @DrPeraltaSPP @EduardoAArias1 @AlcantaraCardio @MarciMonteg @cmdlatrinidad @nachitovaca @urenacard @secardiologia
#PCRLV is the global meeting point for heart valves (London, 16-18 November) 📥Want to submit? Deadline: 2 September (89% acceptance rate) 🫀7 LIVE Centres are confirmed, so join now and don't miss out! pcronline.com/Courses/PCR-Lo… P.S. Early-career practitioner? Choose the aortic,…
Reduced stent strategy versus conventional percutaneous coronary revascularization in patients presenting with STEMI: the COPERNICAN trial #REC #Aheadofprint @drassantos @Borjaibanez1 @ignamatsant revespcardiol.org/en-reduced-ste…
Honored to have our study design published in @RevEspCardiol 🥰 For me, the most fascinating project w the most potential implications for patients in my career hand-in-hand w my friend and co-PI @sjorge4 and the help & commitment of many Spanish investigators @secardiologia
The COPERNICAN trial will be the first randomized study comparing clinical outcomes of drug-coated balloons vs drug-eluting stents in STEMI patients. Read this article published in @RevEspCardiol by @ignamatsant @shci_sec revespcardiol.org/en-reduced-ste…
The COPERNICAN trial will be the first randomized study comparing clinical outcomes of drug-coated balloons vs drug-eluting stents in STEMI patients. Read this article published in @RevEspCardiol by @ignamatsant @shci_sec revespcardiol.org/en-reduced-ste…
Nódulos calcificados en las arterias coronarias: revisión sistemática sobre incidencia y resultados del intervencionismo coronario percutáneo #REC #Aheadofprint @ClaraFdezCordon @Sara_Blasco @ignamatsant revespcardiol.org/es-nodulos-cal…
Welcome to our June 18 issue of #JACCCaseReports @JACCJournals! See our articles with links below. jacc.org/journal/case-r… Full PDF here: jacc.org/doi/10.1016/S2… Video summary here: youtu.be/A-HvfqIqE5Y @MinnowWalsh @DeeDeeWangMD @hmkyale @Justine_Turco Cutting Balloon…
What was your last ACURATE neo TAVR case?? This was ours: “uncrossable” TAV-in-TAV for degenerated SAPIEN-3 Video credits to our fellow @mariogago13 @lamelaspablo @cmdlatrinidad @AndreasRck2 @jorgeachv @ramirotrillo @BSC_EU_Heart @MPAOSS
Nueva prótesis percutánea expandible con balón Myval: revisión sistemática de las indicaciones aórtica, mitral, tricuspídea y pulmonar #REC @mariogago13 @ClaraFdezCordon @jogogh @Carlos_Cortes_V @Sara_Blasco @iamatsantos. revespcardiol.org/es-nueva-prote…